Baduanjin Exercising Effects on Sub-clinical Hypothyroidism and Cognitive Problems

March 27, 2023 updated by: Ali Mohamed Ali ismail, Cairo University

Baduanjin Exercising Effects on Women With Hypothyroidism and Cognitive Problems

Females with sub-clinical hypothyroidism may exhibit frequent cognitive problems especially if they are elderly

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Females (forty in number) with sub-clinical hypothyroidism exhibit cognitive problems, they are elderly, will be divided to exercised group (baduanjin training will be applied 5 times per the week, under supervision for 12 weeks, number of patients will be 20) and other non exercised group (number of patients will be 20) . all women of groups will received their prescribed daily one-dose medication tablet (levothyroxine).

Study Type

Interventional

Enrollment (Anticipated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • Egypt
      • Giza, Egypt
        • Recruiting
        • Cairo Unoversity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 75 years (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • female with sub-clinical hypothyroidism
  • females with mild cognitive impairment
  • females with obesity (obesity class one)

Exclusion Criteria:

  • neurological problems
  • orthopedic problems

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group number 1
Females with sub-clinical hypothyroidism exhibit cognitive problems (mild cognitive impairement), they will be elderly, will receive baduanjin training that will be applied 5 times per the week, under supervision for 12 weeks, number of patients will be 20), also women of this group will receive their prescribed daily one-dose medication tablet (levothyroxine).
Behavioral: Baduanjin exercising
baduanjin will be applied 5 times per the week, under supervision, for 12 weeks,
No Intervention: group number 2
Females with sub-clinical hypothyroidism exhibit cognitive problems (mild cognitive impairement), they will be elderly, will receive will receive their prescribed daily one-dose medication tablet (levothyroxine).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
thyroid stimulating hormone
Time Frame: it will be measured after 12 weeks
will be measured in serum of women with hypothyroidism
it will be measured after 12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
systolic blood pressure
Time Frame: it will be measured after 12 weeks
will be measured by manual sphygmomanometer
it will be measured after 12 weeks
triglycerides
Time Frame: it will be measured after 12 weeks
will be measured in serum of women with hypothyroidism
it will be measured after 12 weeks
Addenbrooke Cognitive Examination
Time Frame: it will be measured after 12 weeks
will assess Cognitive impairment
it will be measured after 12 weeks
diastolic blood pressure
Time Frame: it will be measured after 12 weeks
will be measured by manual sphygmomanometer
it will be measured after 12 weeks
low density lipoprotein
Time Frame: it will be measured after 12 weeks
will be measured in serum of women with hypothyroidism
it will be measured after 12 weeks
cholesterol
Time Frame: it will be measured after 12 weeks
will be measured in serum of women with hypothyroidism
it will be measured after 12 weeks
high density lipoprotein
Time Frame: it will be measured after 12 weeks
will be measured in serum of women with hypothyroidism
it will be measured after 12 weeks
body mass index
Time Frame: it will be measured after 12 weeks
it will be measure on empty bladder and stomach
it will be measured after 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Investigators

  • Principal Investigator: Ali MA Ismail, Cairo University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 18, 2022

Primary Completion (Anticipated)

June 18, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

March 27, 2023

First Submitted That Met QC Criteria

March 27, 2023

First Posted (Actual)

April 7, 2023

Study Record Updates

Last Update Posted (Actual)

April 7, 2023

Last Update Submitted That Met QC Criteria

March 27, 2023

Last Verified

March 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.T.REC/012/004294

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cognitive Impairment

Clinical Trials on Baduanjin exercising

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Romania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe